Consult sources: Supportive care in cancer
Video sources:
Addressing Sexual Health Needs of People with Cancer: What Every Health Professional Should KnowAntibiotics and Biomarkers Management Optimization in Cancer Patients with Fever (This webinar is made possible by sponsorship provided by Thermo Fisher Scientific)Antibody-Drug Conjugates (ADCs)-Induced Nausea and Vomiting and Long-Delayed CINV: New Unmet Medical Needs (This webinar is made possible by sponsorship provided by Helsinn Healthcare SA)Best practices of supportive care in low resource settingsBone Metastases and Exercise (BME) Hub - WebinarCancer Associated Thrombosis: Optimising Patient Care and Navigating Clinical Challenges (This webinar has been sponsored by LEO Pharma A/S)Cancer Therapy and DiarrheaCancer Therapy and Mouth Sores.. Why it happens and what you can do to reduce the riskCancer Therapy and Nausea Cancer Therapy and Your Hair, Skin and NailsCDK 4/6 Inhibitors: Personalizing Treatment Choices and Optimizing Multidisciplinary Care (This webinar is sponsored by Pfizer)Challenges of Antibiotic Management for Cancer Patients in the Emergency Department and Intensive Care Unit (This webinar is made possible by sponsorship provided by Thermo Fisher Scientific)Digital Health and Palliative Care - Exploring the Role of Telemedicine andArtificial IntelligenceEarly-Stage Curative Care: Strategies for Enhancing TreatmentRegimens and Optimizing Chemotherapy Effectiveness (This webinar is made possible by sponsorship provided by Sandoz)Educational Series on Oral Mucositis (OM) Induced by Radiotherapy in Head & Neck Cancer (HNC) - Module 1: Oral Mucositis (OM) - More Than Just Mouth SoresEducational Series on Oral Mucositis (OM) Induced by Radiotherapy in Head & Neck Cancer (HNC) - Module 2: Clinical Prevention & Management of Radiation Induced Mucositis in Head & Neck Cancer (HNC)Gastrointestinal Complications of Immunotherapy and Targeted Agents: Prevention and Treatment Options Webinar - Dr Jervoise AndreyevGastrointestinal Complications of Immunotherapy and Targeted Agents: Prevention and Treatment Options Webinar - Prof Joanne BowenGI Toxicities from Cancer Therapies: Prevention and Management (The webinar is made possible by an unrestricted educational grant from Napo Pharmaceuticals)Home Care / Care Close to Home (2024 Annual Meeting Plenary):
Benefits of Hospital at Home in Cancer Care
The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Post-Surgical Care at Home: How to Empower Patients and Prepare for Follow-Up TreatmentInnovative Approaches in the Management of Bone Metastasis: EnhancingPatient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs)Prevention, and Biosimilars (This webinar is made possible by sponsorship provided by Sandoz)Innovative Implementation and Quality Improvement in Supportive Care (2024 Annual meeting Plenary)
Innovative supportive care provided to refugee children from Ukraine and their families in Spain.
Digital Health Platforms and Innovative technologies for Pediatric oncologic supportive care
Can Digitalization Improve Consideration to & Research for Older Patient with Cancer?Management of Breakthrough Cancer Pain (BTcP) (MASCC and Grünenthal Meds)Management of Emerging Toxicities (2024 Annual Meeting Plenary):
Balancing Success with Toxicity: Identification and Management of Novel Agent Toxicity in Breast Cancer Focusing on Antibody Drug Conjugates
Surviving with Immunotoxicity
Adherence, Survivorship, Long-Term Toxicities (Chronic)Management of Severe Diarrhea in Patients with Cancer and Clinical Practice Guidelines (This webinar has been made possible by an educational grant from Pharmanovia)Managing Menopause After Breast Cancer: Weight, Hot Flashes inRehabilitation (Webinar supported by Nestlé Health Science)MASCC & AORTIC Webinar: Navigating the Psychosocial Aspects of Cancer Screening in Women – African Perspective MASCC Unmet Needs Assessment of Cancer-Related Cognitive Impairment Impact (MASCC COG-IMPACT) - Video OverviewMASCC Webinar: Global Disparities in Supportive Care in Cancer, one size does not fit allMeet the Experts: Working Towards Consistent and Meaningful Mucositis Assessment (This Meet the Experts session is made possible by an unrestricted educational grant from Angelini Pharma S.p.A.)Modern Peer Support: Advances in peer support for people affected by cancer to ensure access and equityMove IT Cancer - The Way to Optimize Cancer Care/Survival: Part 1 Myths and Barriers about Physical Exercise and CancerMove IT Cancer - The Way to Optimize Cancer Care/Survival: Part 2 Panhabilitation in Cancer Care - A Road to Make It RealityNausea and Vomiting During Cancer Course: Back to the Future Webinar (This webinar is made possible by an unrestricted educational grant from Helsinn)Navigating Constipation Care: New Perspectives in OIC (This webinar is made possible by sponsorship provided by Viatris)Navigating the Evolving Landscape in Early Breast Cancer (eBC):Innovations in Treatment, Patient Support, and Digital Resources (Webinar sponsored by Eli Lilly and Company)One Size Does Not Fit All: Personalizing Endocrine Therapy Recommendations in Breast Cancer (This webinar is made possible by an educational grant from Biotheranostics Inc., A Hologic Company)Opioid-Induced Constipation (OIC):
Management and Reassessment (MASCC and Grünenthal Meds)Opioid-Induced Constipation (OIC): Diagnosis, Assessment, and Clinical Features (MASCC and Grünenthal Meds)Optimization of Therapeutic Outcomes for Oncology Patients through Appropriate Skin Care: ISKIMO Expert Consensus (Session supported by La Roche-Posay)Oral Complications of Immunotherapies and TKIs: Similarities and Differences to Conventional Oral Mucositis (MASCC/ISOO webinar).Patient-Centered Communications for Older Adults with CancerPersonalized Care of Patients with BrainMetastases: Optimizing Multidisciplinary CarePre-Clinical and Clinical Perspectives of Physical Exercise for the Prevention and Treatment of Chemotherapy-Induced Peripheral NeurotoxicityPrecision Medicine for Hormone Receptor Positive Breast Cancer: New Therapies and Supportive Care Strategies (Sponsored by Menarini Group/Stemline Therapeutics)Precision Oncology: Improving the Understanding of How Molecular Profiling Improves Breast Cancer CarePrevention of Acute and Persistent Dermatologic Adverse Reactions - How Can Medical Oncologists, Radiation Oncologists and Dermatologists Work Together in Skin, Hair and Nail ToxicitiesSelf-Care After Head-and-Neck RadiationSelf-Care Before Head-and-Neck RadiationSelf-Care During Active ChemotherapySelf-Care During Head-and-Neck RadiationSocial Eating - What Is It, Why It Matters and How It Changes after Head and Neck (HN) CancerSupportive Care and Geriatric Oncology:
Common Goals and Common Challenges - A MASCC/SIOG Nursing & Allied Health Interest Group WebinarThe Great Debate: G-CSF Prophylaxis and Febrile Neutropenia Risk Stratification: Personalizing Treatment Choices and Optimizing Multidisciplinary CareUpdate in Nutrition & Cachexia in Cancer
Web sources:
‘Share your views’—international consultation informs a patient engagement strategy for the Multinational Association of Supportive Care in Cancer15 years supporting adherence to oral anti-cancer treatment: use of the MASCC Oral Agent Teaching Tool (MOATT) worldwide, a review for the future2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomitingA call for continued global collaboration and research for the prevention of breast cancer related arm lymphoedemaA global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathyA perspective on inequities in the management of radiation dermatitisA prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiativeA risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancerA systematic review of dental disease management in cancer patients (This publication has been developed with contributions from MASCC and ISOO)A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions (This publication has been developed with contributions from MASCC and ISOO)A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies (This publication has been developed with contributions from MASCC and ISOO)Accounting for unmet needs resulting from cancer-related cognitive impairmentAdvances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposiumAnamorelin for the Treatment of Cancer Anorexia-Cachexia SyndromeAnticoagulation and bleeding in the cancer patientApplication of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic ReviewAssociations of nutrition impact symptoms with depression in patients with advanced cancerBarrier films and dressings for the prevention of acute radiation dermatitis: A systematic review and meta-analysisBarrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysisBasic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)Bone Metastases and Exercise (BME) Hub - Additional Resources 1Bone Metastases and Exercise (BME) Hub - Additional Resources 2Bone Metastases and Exercise (BME) Hub - Additional Resources 3Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue managementCancer care for transgender and gender-diverse people: Practical, literature-driven recommendations from the Multinational Association of Supportive Care in CancerCancer immunotherapy–related adverse events: causes and challengesCancer survivorship care during COVID-19—perspectives and recommendations from the MASCC survivorship study groupCancer Survivorship in the Indo-Pacific: Priorities for ProgressCancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study GroupCancer-related fatigue self-management: a MASCC-endorsed practice framework for healthcare professionals to optimally support cancer survivorsCare for patients with advanced cancer in the last weeks of life in BrazilCatheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily careClimate change, climate disasters and oncology care: a descriptive global survey of oncology healthcare professionalsClinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers (This publication has been developed with contributions from MASCC and ISOO)Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 updateClinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicitiesClinicians’ experience with topical benzydamine and morphine for the management of oral mucositis: adverse effects and barriersComplexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paperDefining and addressing loneliness in older adults with cancer: an international Delphi consensus from the Multinational Association of Supportive Care in Cancer Geriatrics Study GroupDelphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severityDeveloping alert thresholds and self-management advice for people receiving immune checkpoint inhibitors: a Multinational Association for Supportive Care in Cancer modified Delphi surveyDevelopment of a self-management support practice framework for addressing cancer-related fatigue: a modified Delphi studyDevelopment of the MASCC/ISOO clinical practice guidelinesfor mucositis: an overview of the methodsDiagnosis, Management and Emerging Strategies for Chemotherapy-Induced NeuropathyDisparities in telehealth use: How should the supportive care community respond?Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendationsEffective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient CareEmerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: A MASCC position paper
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agentsEmetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendationEquity, diversity, and inclusion in the Multinational Association for Supportive Care in Cancer: a global membership surveyExercise counselling and referral in cancer care: an international scoping survey of health care practitioners’ knowledge, practices, barriers, and facilitatorsExercise for people with bone metastases: MASCC endorsed clinical recommendations developed by the International Bone Metastases Exercise Working GroupExercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise ProfessionalsFinancial Toxicity in Cancer Supportive Care: An International SurveyFramework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN)Frequency and characteristics of advanced cancer patients with COVID + ve status among inpatient supportive care consults during the pandemic: experience from a tertiary cancer centerFrequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort studyFrom Pathogenesis to Intervention: The Importance of the Microbiome in Oral MucositisGlobal disparities in cancer supportive care: An international surveyGlobal Initiative to Advance Cancer Navigation for Better OutcomesGoing beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship researchGoing beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingGuideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 updateGuideline for the management of fatigue in children and adolescents with cancer or pediatric hematopoietic cell transplant recipients: 2023 updateGuideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 UpdateIncidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs)Inpatient primary prophylaxis of cancer-associated thromboembolism (CAT)Introduction to practical aspects of cancer-associated thrombosis and related complicationsLocal Sociocultural Practice Specific Financial Toxicity Assessment Tool for Cancer: An Emerging NeedLow-risk febrile neutropenia: does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateMultinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesMASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitorsMASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patientsMASCC antiemetic consensus recommendations: resource-limited settingsMASCC antiemetics in advanced cancer updated guidelineMASCC expert opinion/guidance on the use of clinically assisted nutrition in patients with advanced cancerMASCC guideline: cannabis for cancer‑related pain and risk of harms and adverse eventsMASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancerMASCC oncodermatology clinical practice statement: prevention and management of acute radiation dermatitis with Mepitel Film and HydrofilmMASCC recommendations on the management of constipation in patients with advanced cancerMASCC/ISOO Clinical Practice Guidelines for the Managementof Mucositis Secondary to Cancer TherapyMASCC/ISOO clinical practice guidelinesfor the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patientsMASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: Clinical assessment of salivary gland hypofunction and xerostomia in cancer patients (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: dental evaluation and management prior to treatment for hematologic malignancies and CAR T-cell therapy (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: imaging and clinical laboratory tests in the diagnosis and management of medication-related osteonecrosis of the jaw (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: management of oral complications of immunotherapy (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: Management of oral complications of targeted therapyMASCC/ISOO Clinical Practice Statement: Management of oral manifestations of chronic graft-versus-host-disease (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: Management of salivary gland hypofunction and xerostomia in cancer patients (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation (This publication has been developed with contributions from MASCC and ISOO)MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancerMedical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline updateMedication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice GuidelineMepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomized controlled trialsMepitel Film for the prevention of acute radiation dermatitis in head and neck cancer: A systematic review and meta-analysis of randomized controlled trialsMucositis and Infection in Hematology PatientsMultinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitorsMultinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityMultinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsMultinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMultinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendationsMultinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancerMultinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted hydration in patients with advanced cancerMultinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depressionNatural and miscellaneous agents for the prevention of acute radiation dermatitis: A systematic review and meta-analysisOlanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy A Phase 3 Randomized Clinical TrialOpioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guidelineOpioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guidelineOsteonecrosis of the jaw related to non-antiresorptive medications: a systematic reviewPathogenesis of Oral Toxicities Associated with Targeted Therapy and ImmunotherapyPatient and Caregiver Education to Support Self‐Efficacy and Self‐Management During Immunotherapy—An Integrative ReviewPatient navigation across the cancer care continuum: An overview of systematic reviews and emerging literaturePatient perceptions of altering chemotherapy treatment due to peripheral neuropathyPatient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathyPerceived Barriers Toward Patient-Reported Outcome Implementation in Cancer Care: An International Scoping SurveyPhotobiomodulation therapy for the prevention of acute radiation dermatitis: A systematic review and meta-analysisPrediction of mucositis risk secondary to cancer therapy: a systematicreview of current evidence and call to actionPrevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO GuidelinePrevention of acute and delayed chemotherapy-inducednausea and vomiting in pediatric cancer patients: A clinicalpractice guidelinePrevention of radiation dermatitis with skin hygiene and washing: A systematic review and meta-analysisPrimary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in CancerQuality Survivorship Care for People Affected by Advanced or Metastatic Cancer: A Clinical Oncology Society of Australia Endorsement of the Joint Multinational Association of Supportive Care in Cancer and American Society of Clinical Oncology Care Standards and Practice RecommendationsReproductive choice is supportive care in cancerRisk factors associated with venous thromboembolism in breast cancer: a narrative reviewRisk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily careRisks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative reviewSalivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO GuidelineSelf-management support for cancer-related fatigue: A systematic reviewSex-related differences in eating-related distress experienced by patients with advanced cancerShedding light on the management of acute radiation dermatitis: Insight from the MASCC Oncodermatology Study GroupSpinal analgesia in cancer pain management—MASCC general practice recommendationsStrataXRT for the prevention of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomized controlled trialsSupportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi studySupportive Care in Pediatric Oncology: Opportunities and Future DirectionsSurvey of international pediatric nutritional supportive care practices: a report from the Pediatric Study Group of the Multinational Association of Supportive Care in Cancer (MASCC)Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice RecommendationsSurvivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendationsSystematic review and meta-analysis on interventions for radiation dermatitis prevention and management: An overview of the methodsSystematic review of agents for the management of cancertreatment-related gastrointestinal mucositis and clinical practice guidelinesSystematic review of anti-inflammatory agentsfor the management of oral mucositis in cancer patients and clinicalpractice guidelinesSystematic review of antimicrobials, mucosal coating agents,anesthetics, and analgesics for the management of oral mucositisin cancer patients and clinical practice guidelinesSystematic review of basic oral care for the management of oralmucositis in cancer patients and clinical practice guidelinesSystematic review of growth factors and cytokinesfor the management of oral mucositis in cancer patients and clinical practice guidelinesSystematic review of natural and miscellaneous agents,for the management of oral mucositis in cancer patients and clinicalpractice guidelines — part 2: honey, herbal compounds, salivastimulants, probiotics, and miscellaneous agentsSystematic review of natural and miscellaneous agentsfor the management of oral mucositis in cancer patients and clinicalpractice guidelines—part 1: vitamins, minerals, and nutritionalsupplementsSystematic review of oral cryotherapy for the management of oralmucositis in cancer patients and clinical practice guidelinesSystematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelinesSystematic review of the tools and outcomes for the assessment of acute radiation dermatitis severityTelehealth in Oncology: ASCO Standards and Practice RecommendationsThe effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: A systematic review and meta-analysisThe effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviewsThe efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviewsThe impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practiceThe MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in CancerThe MASCC COG-IMPACT: The COSA Endorsement of a MASCC Developed Unmet Needs Assessment Tool for Cancer-Related Cognitive Impairment ImpactThe MASCC Textbook of Cancer Supportive Care and SurvivorshipThe MASCC/ISOO Mucositis Guidelines 2019 Update: introductionto the first set of articlesThe MASCC/ISOO mucositis guidelines 2019: the second set of articlesand future directionsThe Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of LifeThe Rise of Supportive Oncology: A Revolution in Cancer CareThe role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensusThe Supportive Care 2030 Movement - Ambition StatementsThe use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitionersThrombosis, cancer, and COVID-19Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapiesTo extract or not extract teeth prior to head and neck radiotherapy? A systematic review and meta-analysis (This publication has been developed with contributions from MASCC and ISOO)Topical corticosteroids for the prevention of severe radiation dermatitis: A systematic review and meta-analysisTopical non-steroidal agents for the prevention of radiation dermatitis: A systematic review and meta-analysisTreatment and secondary prophylaxis of venous thromboembolism in cancer patientsTreatment of breakthrough and prevention of refractorychemotherapy-induced nausea and vomiting in pediatric cancerpatients: Clinical practice guideline updateUnmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping reviewUpdated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO frameworkUse of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline - 2What lurks beneath the symptom? Why more basic scientists are needed in cancer supportive care and survivorship research